Yale Bulletin and Calendar

January 11, 2008|Volume 36, Number 14


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Mutant gene identified as ‘villain’
in hardening of the arteries

A genetic mutation expands lesions in the aorta and promotes coronary atherosclerosis, more commonly known as hardening of the arteries, according to a study by Yale School of Medicine researchers in Cell Metabolism.

The researchers found that mice engineered without the Akt1 gene and fed a high cholesterol diet had many more signs of aortic atherosclerosis compared to their littermates. And, surprisingly, their coronary lesions were similar to humans, say the ­scientists.

“About 20% of the mice died spontaneously, perhaps due to an acute heart attack,” says William Sessa, senior author of the study, professor of pharmacology, and director of Yale’s vascular biology and therapeutics program.

Atherosclerosis is a chronic inflammatory response in arterial walls, in large part due to deposits of lipoproteins — which are plasma proteins that carry cholesterol and triglycerides. The “hardening” or “furring” of the arteries is caused by plaque formation.

In the vascular wall, Akt1 plays an important role in regulating the development of endothelial cells, which line the entire circulatory system, from the heart to the smallest capillary. Endothelial cells play an important role in regulating blood pressure, in blood clotting, in plaque formation in the arteries and in formation of new blood vessels.

“The major finding of this study is that an absence of Akt1 aggravates atherosclerotic lesions, promotes coronary atherosclerosis, and may be a model of acute coronary syndromes,” Sessa says. “Specific activation of Akt1 may provide a therapeutic approach to decrease formation of lesions in the arterial wall and promote plaque stabilization to prevent an acute heart attack.”

One concern, he notes, is that specific drugs are being developed to inhibit Akt1 in cancer patients to reduce progression of tumors, and that these drugs may also promote hardening of the arteries.

Co-authors include Carlos Fernandez-Hernando, Eric Ackah, Jun Yu, Yajaira Suarez, Takahisa Murata, Yasuko Iwakiri, Jay Prendergast and Robert Miao, of Yale, and Morris Birnbaum of the Howard Hughes Medical Institute and the University of Pennsylvania School of Medicine.

By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

University is increasing payout from endowment

Stern named to third term as dean of School of Architecture

Findings set stage for prevention of epilepsy

Antibody may delay development of diabetes

Scientists determine intricate process used in assembly . . .

Mutant gene identified as ‘villain’ in hardening of the arteries

Researchers find gene that protects newborns . . .

Yale Rep stages the world premiere of ‘The Evildoers’

Exhibit reveals the ways in which mathematics . . .

Advocates for universal preschools win Grawemeyer Award . . .

Two medical school researchers win awards . . .

Lewis Walpole Library celebrates re-opening with exhibition

Peabody to honor Martin Luther King Jr.’s legacy with festival

Stanton Wheeler, was musician, master, sociologist and sports fan

Change of venue for Waith memorial

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home